News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Interpharm Holdings, Inc. (IPA) Announces Closing Of $10 Million Capital Financing



6/2/2006 11:58:33 AM

HAUPPAUGE, N.Y.--(BUSINESS WIRE)--June 2, 2006--Interpharm Holdings, Inc. (Amex: IPA - News), a manufacturer and distributor of generic pharmaceuticals, today announced it has closed its $10 million capital financing with Tullis-Dickerson Capital Focus III, L.P., ("Tullis-Dickerson"). A full description of the Tullis-Dickerson stock purchase agreement, pursuant to which Tullis-Dickerson purchased Series B-1 Convertible Preferred Stock ("Series B-1") and warrants, as well as a copy of the agreement, are provided in a Current Report on Form 8-K filed by Interpharm with the SEC on May 19, 2006. The Series B-1 stock is convertible into an aggregate of approximately 6.5 million shares of Interpharm common stock at $1.53 per share, and the warrants, which have an exercise price of $1.639 per share, are exercisable for an aggregate of 2,281,914 shares of common stock.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES